Both the RAS-RAF-MEK-ERK1/2 and PI3K/Akt pathways are activated downstream of the chronic myeloid leukaemia BCR-ABL fusion protein. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.